Per Richard Torbjörn Hallberg
Director/Board Member at DOVA PHARMACEUTICALS, INC.
Net worth: 698 450 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Guido Oelkers | M | 59 |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | 7 years |
Henrik Stenqvist | M | 57 |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | 6 years |
Annette Clancy | F | 70 | 10 years | |
Bart Fynaerts | M | - |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | 3 years |
Helena Ildiko Saxon | F | 54 | 13 years | |
Mahmood Ladha | M | 60 | 5 years | |
Filippa Stenberg | F | - | - | |
Armin Reininger | M | 67 | 7 years | |
Åke Mikael Smedeby | M | 56 |
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | 27 years |
Staffan Schüberg | M | 55 | 4 years | |
Sven Anders Ullman | M | 68 | 3 years | |
Ghita Astrup | F | - |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | 13 years |
Soufiane Fahmy | F | - |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | 3 years |
Lydia Abad-Franch | M | - | - | |
Christine Wesström | F | 49 | 14 years | |
Pablo de Mora | M | 56 | 5 years | |
Daniel Rankin | M | 44 | 7 years | |
Marc Banjak | M | - | - | |
Norbert Oppitz | M | 57 | 7 years | |
Bill L. Nichols | M | - | 6 years | |
Stephen Crane | M | - | - | |
Caroline Diaz | F | - | - | |
Russell Schundler | M | 49 | - | |
Matthew Robert Iles | M | - |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | 8 years |
Jean Luc Delay | M | - |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | 8 years |
Lena Bjurner | F | 56 | 1 years | |
Rami Levin | M | 55 |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | - |
Lee F. Allen | M | 72 | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bo Jesper Hansen | M | 66 | 2 years | |
David Zaccardelli | M | 59 | 1 years | |
Wills Hughes-Wilson | F | 53 | 6 years | |
Kristin Strandberg | F | 35 | - | |
Nancy Wysenski | F | 66 | 1 years | |
Sven Håkan Björklund | M | 68 | 7 years | |
Lena Elisabeth Svanberg | M | 63 | - | |
Roger Jeffs | M | 62 | 2 years | |
Thomas Kudsk Larsen | M | 50 | 2 years | |
Johannes G. C. P. Schikan | M | 66 | 9 years | |
David Allsop | M | - | - | |
Steven M. Goldman | M | 72 | 2 years | |
Paul Manning | M | 68 | 3 years | |
Paula Treutiger | F | 57 | 3 years | |
Alfred Novak | M | 76 | 2 years | |
Ravi Rao | M | 55 | 2 years | |
Milan Zdravkovic | M | 54 | 4 years | |
Emily Chamberlain | F | 34 | - | |
Karin Eklund Vanderpol | F | 51 | - | |
Erika Husing | F | 51 | - | |
Linda Nordlöf | F | - | 3 years | |
Jason Hoitt | M | 46 | 1 years | |
Anne Marie de Jonge Schuermans | M | 52 | 4 years | |
Fredrik Wetterlundh | M | 58 | 2 years | |
Holly May | F | - | 1 years | |
Amy Pott | F | 47 | - | |
Philip Wood | M | 56 | 9 years | |
An van Es-Johansson | M | 64 | 13 years | |
Lars Dreiøe | M | 57 | 3 years | |
Mogens Gisselbaeck | M | - |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | 2 years |
Kirsti Gjellan | M | 61 | 5 years | |
Krassimir Mitchev | M | - | 5 years | |
Hege Hellstrom | M | 59 | 5 years | |
Stephen James | M | 58 | 8 years | |
Sean Stalfort | M | 54 | 3 years | |
Mats-Olof Wallin | M | 73 | 5 years | |
Claes Lindblad | M | 57 |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | 3 years |
Michael Seckler | M | 59 |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | 16 years |
Matthew David Tooth | M | 49 | - | |
Mark Hahn | M | 61 | 1 years | |
William N. Garbarini | M | - |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | - |
Anton Hoos | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 47 | 67.14% |
United States | 21 | 30.00% |
Finland | 3 | 4.29% |
Belgium | 2 | 2.86% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Per Richard Torbjörn Hallberg
- Personal Network